Response to the Comment on "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO-Metastatic Tumor Burden in the Future Liver Remnant for Decision-making of Staged Hepatectomy"

Ann Surg. 2021 Dec 1;274(6):e750-e751. doi: 10.1097/SLA.0000000000004014.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Hepatectomy*
  • Humans
  • Liver*
  • Portal Vein
  • Survival Analysis
  • Thyrotropin
  • Tumor Burden

Substances

  • Thyrotropin